Healthcare provider profile · identity verified

Joseph M Brewster, MD

Family Practice · SCOTTSDALE, AZ · NPI 1871544122

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	381	136
Levothyroxine Sodium	Levothyroxine Sodium	232	82
Amlodipine Besylate	Amlodipine Besylate	214	85
Lisinopril	Lisinopril	181	74
Losartan Potassium	Losartan Potassium	173	66
Rosuvastatin Calcium	Rosuvastatin Calcium	159	61
Gabapentin	Gabapentin	111	32
Hydrochlorothiazide	Hydrochlorothiazide	111	38
Zolpidem Tartrate	Zolpidem Tartrate	111	27
Tamsulosin Hcl	Tamsulosin Hcl	96	36
Metformin Hcl	Metformin Hcl	92	39
Trazodone Hcl	Trazodone Hcl	88	38
Omeprazole	Omeprazole	87	39
Escitalopram Oxalate	Escitalopram Oxalate	82	31
Metoprolol Succinate	Metoprolol Succinate	80	33
Pantoprazole Sodium	Pantoprazole Sodium	68	35
Sertraline Hcl	Sertraline Hcl	68	27
Simvastatin	Simvastatin	63	22
Doxycycline Hyclate	Doxycycline Hyclate	52	47
Alprazolam	Alprazolam	47	15
Methylprednisolone	Methylprednisolone	47	43
Clonazepam	Clonazepam	44	14
Allopurinol	Allopurinol	43	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	22
Carvedilol	Carvedilol	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	11
Pravastatin Sodium	Pravastatin Sodium	29	11
Finasteride	Finasteride	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	12
Alendronate Sodium	Alendronate Sodium	26	suppressed
Glipizide	Glipizide	25	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Ozempic	Semaglutide	21	suppressed
Mounjaro	Tirzepatide	20	suppressed
Furosemide	Furosemide	19	suppressed
Potassium Chloride	Potassium Chloride	19	12
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Azithromycin	Azithromycin	18	16
Jardiance	Empagliflozin	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	16	suppressed
Famotidine	Famotidine	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Topiramate	Topiramate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	12
Valsartan	Valsartan	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Ramipril	Ramipril	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Naproxen	Naproxen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error